Active Ulcerative Colitis
Immunology
3
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
2
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Tillotts PharmaAsacol®
Ferring Pharmaceuticals5-ASA
BiogenBG9418
Clinical Trials (3)
Total enrollment: 411 patients across 3 trials
Comparative Efficacy and Safety Study in Patients With Active Ulcerative Colitis
Start: Nov 2010Est. completion: Mar 2013
Phase 3Completed
Canadian Active & Maintenance Modified Pentasa Study
Start: Oct 2007Est. completion: May 2011288 patients
Phase 3Completed
A Phase 2 Study of Interferon Beta-1a (Avonex®) in Ulcerative Colitis
Start: May 2008Est. completion: Mar 2010123 patients
Phase 2Completed
Related Jobs in Immunology
Regulatory Affairs Manager(Immunology), Korea
AbbVie
Seoul, Seoul
10h ago
Regional Sales Trainer - Rheumatology (Mid Atlantic/Central)
AbbVie
Remote
11h ago
Field Reimbursement Manager - Rheumatology - Seattle, WA (North)
Johnson & Johnson
Seattle, Washington, United States of America
Yesterday
$100K - $175K/yr
Senior Medical Science Liaison, Dermatology - Indianapolis
Johnson & Johnson
Indianapolis, Indiana, United States
Yesterday
$137K - $236K/yr
Senior Area Business Specialist, Immunology - Detroit, MI - Johnson & Johnson Innovative Medicine
Johnson & Johnson
Detroit, Michigan, United States
Yesterday
Senior Clinical Trial Physician, Rheumatology
Bristol Myers Squibb
Princeton - NJ - US
Yesterday
$309K - $374K/yr
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 late-stage (Phase 3) programs — potential near-term approvals
3 companies competing in this space